What is Kura Oncology Inc (KURA)?
Kura Oncology Inc is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapies for cancer treatment. The company’s research emphasizes small molecule inhibitors designed to interfere with specific molecular pathways involved in tumor growth and progression. Kura Oncology's pipeline includes candidates aimed at hematologic malignancies and solid tumors. The company employs a precision medicine approach, utilizing biomarkers to identify patient populations most likely to benefit from its therapies. Kura Oncology collaborates with research institutions and industry partners to advance its drug candidates through clinical development.
Kura Oncology Inc Stock Price Today: Live Overview
The price today is shaped by trading dynamics as Kura Oncology Inc is valued at $8.69. Intraday movement has ranged from $8.5 to $8.94 with a daily percentage change of 0%.
FAQ: Kura Oncology Inc (KURA)
What is the current price of KURA stock?
The last traded price is $8.69.
Does KURA pay dividends?
Kura Oncology Inc does not pay dividends.
Does KURA have a formal corporate presence or regional headquarters in the UAE?
Kura Oncology Inc operates through partners in the UAE without an official office or subsidiary.
What is KURA best known for?
Kura Oncology Inc is most famous for its development of precision medicines for cancer treatment.
What assets are typically shown together with KURA?
Commonly shown alongside KURA: Benitec Biopharma Inc., Medpace Holdings Inc, C4 Therapeutics, Inc.
Latest shares articles



